eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Laboratorios Casen Fleet S.L.U
Autovia De Logrono KM 13, 3 Utebo-Zaragoza, 50180, Spain
Telephone: +34976462626
Telephone: 07792 983959 (UK Sales enquiries)
Telephone: 08082343863 - FREE TOLL NUMBER UK.
Fax: +34976771560
E-mail: pwilliams@casenfleet.com (UK Sales enquiries)
E-mail: barajasc@cbfleet.com (PV matters)
E-mail: centrodeinformacion@casenfleet.com
WWW: http://www.casenfleet.com
Medical Information Direct Line: +34913517964
Customer Care direct line: +34913518800
Medical Information Fax: +34913518799

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 23/06/2011
PIL Fleet Phospho-Soda

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 30/06/2010 and displayed until 23/06/2011
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 22/12/2009 and displayed until 30/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change due to user-testing of patient information
Updated on 08/09/2008 and displayed until 22/12/2009
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 21/07/2008 and displayed until 08/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/11/2007 and displayed until 21/07/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 25/09/2007 and displayed until 14/11/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 03/07/2003 and displayed until 25/09/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 25/09/2002 and displayed until 03/07/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC